THIS IS A SOURCES SOUGHT ANNOUNCEMENT ONLY.
It is neither a solicitation announcement nor a request for proposals or quotes and does not obligate the Government to award a contract. Requests for a solicitation will not receive a response. Responses to this sources sought must be in writing. The purpose of this sources sought announcement is for market research to make appropriate acquisition decisions and to gain knowledge of potential qualified Small Businesses interested and capable of providing the services described below.
The information gained from this market research will help the National Institutes (NIH), Clinical Center, Department of Laboratory Medicine plan for its acquisition strategy.
Potential Large and Small Businesses shall include business information outlined in the section below as a part of their response.
POTS: 25-000204
Complete responses to this notice shall be in the following format:
- SAM UEI Number
- Company Name
- Company Address, City, State and Zip Code
- Company Point of Contact, Email Address and Telephone Number
- Current GSA Schedule appropriate to this Sources Sought
- Socioeconomic Status: (i.e., HUBZone, 8a, Small Business, Women Owned Small Business, Veteran-Owned Small-Business, etc.) as validated in Central Contractor Registration (CCR). All offerors must register in CCR located in https://www.sam.gov.
- Provide a capability statement that addresses the organizations qualifications and ability to perform as a contractor for the work described in the Statement of Work.
*****************************************************************************
The National Institutes of Health, Clinical Center, Department of Laboratory Medicine has a requirement for a contractor to provide Roche Cobas® 6000 Reagents, Consumables and Preventative Maintenance Services.
The Department of Laboratory Medicine, Immunoassay Section has a continued need for Roche reagents, consumables, and preventative maintenance services. The Roche Cobas 6000 System can only use Roche proprietary reagents and consumables. The Roche Cobas 6000 is an excellent robust instrument providing reliable results and performance along with an excellent maintenance service record. The large test menu provides state of the art laboratory testing necessary to support the Clinical Center for patient care and research testing providing high volume needs as well as rapid turnaround times for clinical testing. The Department of Laboratory Medicine, Immunoassay Section owns one (1) Roche Cobas® 6000 system used to perform forty (40) chemistry and immunoassay tests for the monitoring of patient care, diagnosis of various diseases, and research protocols. Some of the tests includes: The core test menu consists of ACE, Free Fatty Acids, Cancer Antigen 15-3, Cancer Antigen 19-9, C-Peptide, Insulin, Osteocalcin, Parathyroid Hormone, Rubella IgG, Toxoplasma IgG, Pro-BNP, CKMB, Cystatin-C, SARS-CoV-2 anti-N, SARS-CoV-2 anti-S, Albumin, Alkaline Phosphatase, Alanine Transaminase, Amylase, Aspartate Aminotransferase, Blood Urea Nitrogen, Direct Bilirubin, Calcium, Chloride, Cholesterol, Creatine Kinase, Creatinine, Carbon Dioxide, Glucose, Lactate Dehydrogenase, Magnesium, Potassium, Sodium, Phosphorus, Total Bilirubin, Total Protein, Triglycerides, Uric Acid, Serum Indices.
Period of Performance: 02/01/2025 to 01/31/2026.
Delivery Schedule:
Reagents and consumables will be delivered on an as needed Basis. Preventative maintenance and repair services will be performed by an authorized and trained service technician in accordance with the original manufacturer recommendations.
Delivery Location:
Deliver to:
Attention: TBD
National Institutes of Health
10 Center Drive
Building 10, Room TBD
Bethesda, MD 20892-1288
Contractors shall not reach out to the customer for any questions or clarifications.
All communications must go through contracting.
******************************************************************************
Important information: The Government is not obligated to nor will it pay for or reimburse any costs associated with responding to this source sought synopsis request. This notice shall not be construed as a commitment by the Government to issue a solicitation or ultimately award a contract, nor does it restrict the Government to a particular acquisition approach. The Government will in no way be bound to this information if any solicitation is issued. No sub-contracting opportunity is anticipated.
NAICS: The North American Classification System (NAICS) code for this acquisition is 325413- In Vitro Diagnostic Substance Manufacturing (Small Business Size Standards 1,250 Average Number of Employees)
PSC: 6550- In Vitro Diagnostic Substances, Reagents, Test Kits and Sets
Notice to potential offerors: All offerors who provide goods or services to the United States Federal Government must be registered and have an active registration in the System for Award Management (SAM) at www.sam.gov and complete Online Representations and Certifications Application (ORCA).
All interested Offerors should submit information by e-mail to sheri.eiri@nih.gov
All information submissions shall be received no later than 12:00 pm Eastern Standard Time, November 28, 2024.
